Clinical Trial Update: Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nimotuzumab with radiotherapy and temozolomide for glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED